China NMPA Inspection - Guangdong Saint Vincent Fine Chemical Co., Ltd. - January 08, 2020

The National Medical Products Administration (NMPA) of China issued an official notification on January 8, 2020, announcing an unannounced inspection conducted at Guangdong Shengvina Fine Chemical Co., Ltd. This public notice, identified by the index number JGXX-2020-10001, serves as a formal announcement of regulatory oversight by the NMPA. The purpose of such unannounced inspections is to ensure compliance with relevant drug and cosmetic supervision regulations within China's pharmaceutical and chemical industry. However, the provided document is limited to the announcement itself. It does not disclose the specific dates on which the inspection occurred, nor does it contain any details regarding the main findings, such as identified violations or issues, or any corrective actions that may have been mandated as a result of the inspection. Consequently, while the regulatory body and the subject company are clearly identified, the operational specifics of the inspection and its outcomes are not present in this notification.